In laboratory studies, GHK-Cu demonstrates the ability to modulate gene expression, promote angiogenesis, and assist in the repair of damaged skin and connective tissue
For patients exploring what drugs are used for COVID long haulers, integrating a powerful antioxidant like liposomal glutathione alongside prescribed mast cell stabilizers can provide a synergistic approach to managing complex, overlapping symptom clusters
A transparent explanation of evidence limitations and surgical risk priorities is more likely to preserve trust and compliance than confrontational dismissal
State of the clinical research For both compounds, the published clinical research in humans is limited: BPC-157 has not received approval as a medicine in any major regulatory jurisdiction (UK MHRA, EU EMA, US FDA)
Some individuals may also combine glutathione with vitamin C for enhanced antioxidant effects, based on professional advice